National reimbursement for drugs is mainly regulated by the joint federal committee (G-BA) in Germany. However, when it comes to the management and organization of regional drug budgets and the controlling mechanisms the Association of Statutory Physicians (KVs) are a main stakeholder. Various tools exist which also vary between German regions and could have a positive or negative impact on market uptake. The regional specifics will be discussed between Dr. Stefan Walzer (MArS) and Dr. Mathias Flume (KV Westphalia-Lippe).
Regional drug budgets – KVs as hidden watch dogs in Germany!?C T2023-02-12T05:19:06-05:00
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.